NBEO Pharmacology Practice Exam 2025 – Complete Study Guide

RIPE therapy refers to a standard regimen used for the treatment of active tuberculosis. This acronym stands for four core medications: Rifampin, Isoniazid, Pyrazinamide, and Ethambutol. Each of these medications plays a crucial role in combating the Mycobacterium tuberculosis bacteria, which causes tuberculosis.

In the context of the question, Enrofloxacin is not a component of RIPE therapy. This antibiotic belongs to the fluoroquinolone class and is primarily used in veterinary medicine, making it unsuitable for the standard treatment of tuberculosis in humans. Therefore, it does not fit with the established components of the RIPE regimen, which specifically targets tuberculosis.

Understanding the specific roles and classifications of different antibiotics is essential in pharmacology. This knowledge aids in recognizing which medications are appropriate for certain conditions and which are not part of a specific treatment protocol, such as RIPE therapy for tuberculosis.